X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2168) 2168
Publication (149) 149
Book Review (44) 44
Book Chapter (14) 14
Conference Proceeding (4) 4
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tocilizumab (2076) 2076
index medicus (1090) 1090
humans (992) 992
rheumatology (833) 833
rheumatoid arthritis (829) 829
female (588) 588
male (495) 495
interleukin-6 (460) 460
middle aged (429) 429
arthritis, rheumatoid - drug therapy (428) 428
antibodies, monoclonal, humanized - therapeutic use (424) 424
treatment outcome (400) 400
double-blind (397) 397
antirheumatic agents - therapeutic use (354) 354
adult (353) 353
arthritis (309) 309
aged (300) 300
methotrexate (294) 294
rheumatoid-arthritis (254) 254
therapy (254) 254
il-6 (250) 250
medicine & public health (228) 228
immunology (216) 216
rituximab (207) 207
disease-activity (202) 202
cytokines (194) 194
efficacy (193) 193
rheumatoid factor (192) 192
inflammation (186) 186
infliximab (181) 181
etanercept (172) 172
abatacept (171) 171
disease (168) 168
drug therapy (168) 168
care and treatment (160) 160
safety (160) 160
inadequate response (157) 157
pharmacology & pharmacy (153) 153
adalimumab (146) 146
antibodies, monoclonal, humanized - adverse effects (145) 145
juvenile idiopathic arthritis (142) 142
interleukin 6 (141) 141
internal medicine (141) 141
antirheumatic agents - adverse effects (140) 140
interleukins (135) 135
severity of illness index (134) 134
modifying antirheumatic drugs (133) 133
receptors, interleukin-6 - antagonists & inhibitors (133) 133
trial (132) 132
animals (131) 131
musculoskeletal diseases (128) 128
remission (127) 127
antibodies, monoclonal - therapeutic use (125) 125
giant cell arteritis (124) 124
medicine, general & internal (124) 124
monoclonal antibodies (124) 124
antibodies, monoclonal, humanized - administration & dosage (123) 123
patients (122) 122
analysis (120) 120
drug therapy, combination (117) 117
biologics (113) 113
interleukin-6 receptor inhibition (109) 109
abridged index medicus (104) 104
interleukin-6 - antagonists & inhibitors (103) 103
anakinra (102) 102
monotherapy (102) 102
health aspects (101) 101
placebo-controlled trial (99) 99
skin and connective tissue diseases (99) 99
antirheumatic agents - administration & dosage (98) 98
research (98) 98
treatment (98) 98
antibodies, monoclonal, humanized (97) 97
corticosteroids (93) 93
retrospective studies (93) 93
tumor necrosis factor-alpha - antagonists & inhibitors (87) 87
methotrexate - therapeutic use (85) 85
anti-interleukin-6 receptor antibody (84) 84
antibody (84) 84
biological products - therapeutic use (83) 83
monoclonal-antibody (83) 83
remission induction (83) 83
adolescent (81) 81
multicenter (81) 81
antibodies, monoclonal, humanized - pharmacology (80) 80
interleukin-6 - metabolism (80) 80
young adult (80) 80
clinical trials (78) 78
risk factors (78) 78
takayasu arteritis (78) 78
children (77) 77
receptors, interleukin-6 - immunology (77) 77
diagnosis (76) 76
medical research (76) 76
medicine (76) 76
time factors (76) 76
tumor necrosis factor-tnf (76) 76
arthritis, rheumatoid - immunology (75) 75
antirheumatic agents (74) 74
pathogenesis (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1883) 1883
French (81) 81
German (52) 52
Japanese (47) 47
Russian (43) 43
Spanish (37) 37
Czech (11) 11
Portuguese (8) 8
Polish (6) 6
Korean (5) 5
Hungarian (3) 3
Italian (3) 3
Slovak (2) 2
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 01/2017, Volume 35, Issue 1, pp. 170 - 171
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2019, Volume 60, Issue 9, pp. 2101 - 2103
Acute graft versus host disease (aGVHD) was first described by Barnes et al. in 1962, who reported a 'secondary disease' in mice after irradiation and infusion... 
Tocilizumab | IL-6 blockade | GVHD
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 12/2017, Volume 56, Issue 12, pp. 2044 - 2045
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 06/2019, Volume 58, Issue 6, pp. 1056 - 1064
Objectives. This post hoc analysis of the TOZURA study programme evaluated the efficacy and safety of subcutaneous tocilizumab (TCZ-SC) as monotherapy or with... 
glucocorticoid | tocilizumab | biologic therapies | csDMARDs | MODIFYING ANTIRHEUMATIC DRUGS | PLACEBO | MONOTHERAPY | EFFICACY | RHEUMATOLOGY | COMBINATION | INTRAVENOUS TOCILIZUMAB | TRADITIONAL DMARDS | LONG-TERM SAFETY | DOUBLE-BLIND | INTERLEUKIN-6 RECEPTOR INHIBITION | Clinical Science
Journal Article
RHEUMATOLOGY, ISSN 1462-0324, 07/2019, Volume 58, Issue 7, pp. 1274 - 1284
Objectives To compare retention of tocilizumab (TCZ) as monotherapy vs combination therapy with MTX in RA patients achieving clinical improvements during the... 
drug retention | MODIFYING ANTIRHEUMATIC DRUGS | MONOTHERAPY | INADEQUATE RESPONSE | methotrexate | OPEN-LABEL | RHEUMATOLOGY | rheumatoid arthritis | SUBCUTANEOUS TOCILIZUMAB | INTRAVENOUS TOCILIZUMAB | efficacy loss | tocilizumab | DISEASE-ACTIVITY INDEX | DOUBLE-BLIND | INTERLEUKIN-6 RECEPTOR INHIBITION | BIOLOGIC-NAIVE | Clinical Science
Journal Article
The Korean Journal of Internal Medicine, ISSN 1226-3303, 2019, Volume 34, Issue 4, p. 917
Background/Aims: To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with... 
Tocilizumab | Korean | Arthritis | rheumatoid
Journal Article
Internal Medicine, ISSN 0918-2918, 2017
TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, pleural effusion, fever, renal dysfunction, reticulin fibrosis of the... 
TAFRO syndrome | tocilizumab | cyclophosphamide
Journal Article
CLEVELAND CLINIC JOURNAL OF MEDICINE, ISSN 0891-1150, 07/2019, Volume 86, Issue 7, pp. 437 - 438
Journal Article
Revista Clinica Espanola, ISSN 0014-2565, 08/2018, Volume 218, Issue 6, pp. 298 - 304
The available treatments for systemic sclerosis (SS) have limited effectiveness. Treatment with tocilizumab (TCZ), a biological drug that inhibits interleukin... 
Tocilizumab | Systemic sclerosis | Treatment
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 08/2015, Volume 67, Issue 8, pp. 2056 - 2060
Objective. To investigate whether leucine-rich alpha(2)-glycoprotein (LRG) could be a biomarker for disease activity during interleukin-6 (IL-6) blockade... 
DISEASE | ANTIBODY | RHEUMATOLOGY | ALPHA-2 GLYCOPROTEIN | TOCILIZUMAB
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 2014, Volume 32, Issue 6, pp. 4 - S4
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 08/2019, Volume 49, Issue 1, pp. 126 - 135
Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and... 
Giant cell arteritis | Biological therapy | Large-vessel vasculitis | Tocilizumab | REFRACTORY UVEITIS | EFFICACY | POLYMYALGIA-RHEUMATICA | CLASSIFICATION | BEHCETS-DISEASE | INDUCTION | RHEUMATOLOGY | MAINTENANCE | THERAPY | RECEPTOR TOCILIZUMAB | REMISSION | Medicine, Experimental | Medical research
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 03/2018, Volume 85, Issue 2, pp. 210 - 211
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 01/2018, Volume 85, Issue 1, pp. 54 - 60
L’immunogénicité du tocilizumab (TCZ) a été peu étudiée. Nous avons évalué l’immunogénicité du TCZ et les taux sériques résiduels de TCZ chez des patients... 
Tocilizumab | Immunogénicité | Polyarthrite rhumatoïde
Journal Article
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, ISSN 1744-666X, 02/2013, Volume 9, Issue 2, pp. 104 - 104
Journal Article
Revista Colombiana de Reumatologia, ISSN 0121-8123, 10/2018, Volume 25, Issue 4, pp. 298 - 300
Cogan's syndrome is a chronic inflammatory disease typified by interstitial keratitis and Meniere-like auditory involvement, and it can be accompanied by... 
Tocilizumab | Vasculitis | Cogan syndrome
Journal Article
臨床リウマチ, ISSN 0914-8760, 2015, Volume 27, Issue 3, pp. 184 - 188
Journal Article
Cancer Discovery, ISSN 2159-8274, 12/2017, Volume 7, Issue 12, pp. 1404 - 1419
Lymphodepletion chemotherapy followed by infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells can be complicated by neurologic adverse... 
SUSTAINED REMISSIONS | MANAGEMENT | B-CELL | ONCOLOGY | THROMBOSIS | MALIGNANCIES | SERUM | CHIMERIC ANTIGEN RECEPTOR | LEUKEMIA | PERICYTES | TOCILIZUMAB | chimeric antigen receptor | neurotoxicity | cytokine release syndrome | CAR | CD19
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.